Patents Assigned to Link Pharmaceuticals Limited
  • Anti-emetic pharmaceutical compositions containing methotrimeprazine
    Patent number: 6159965
    Abstract: A non-sedating anti-emetic composition in oral unit dosage form comprising from 1 to 5 mg of methotrimeprazine per unit dosage, or in unit dosage form for parenteral administration comprising from 1 to 5 mg of methotrimeprazine in each unit dosage.
    Type: Grant
    Filed: December 2, 1997
    Date of Patent: December 12, 2000
    Assignee: Link Pharmaceuticals Limited
    Inventors: Philip Malcolm Hallwood, Grahame David Barkby